Stabilized Ortho-Silicic Acid as a Modifier of Tissue-Preliminary Comparative Biomaterial Studies.


Journal

Journal of biomedical nanotechnology
ISSN: 1550-7033
Titre abrégé: J Biomed Nanotechnol
Pays: United States
ID NLM: 101230869

Informations de publication

Date de publication:
01 Apr 2020
Historique:
entrez: 24 9 2020
pubmed: 25 9 2020
medline: 20 11 2020
Statut: ppublish

Résumé

The ortho-silicic acid (H₄SiO₄) plays an essential role in delivering silicon to body cells and the monomeric ortho-silicic acid is the most bioavailable source of silicon for humans. This study reveals that the ortho-silicic acid (OSA) modifies the tissue of a healthy and pathological hypotrophic amnion, thermal burn skin and, additionally, the OSA-incubated serum. Changes in the tissue modified by the ortho-silicic acid were traced on the molecular level with the use of FTIR spectroscopy. The most interesting area of tissue modification with the use of OSA acid solutions is the appearance of the 1085 cm

Identifiants

pubmed: 32970985
doi: 10.1166/jbn.2020.2912
doi:

Substances chimiques

Biocompatible Materials 0
Silicic Acid 1343-98-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

538-547

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH